Invention Grant
- Patent Title: Anti-galectin-1 (Gal1) monoclonal antibodies and fragments thereof for neutralizing Gal1
-
Application No.: US17065151Application Date: 2020-10-07
-
Publication No.: US11673956B2Publication Date: 2023-06-13
- Inventor: Margaret A. Shipp , Jing Ouyang , Scott J. Rodig
- Applicant: Dana-Farber Cancer Institute, Inc.
- Applicant Address: US MA Boston
- Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Foley Hoag LLP
- The original application number of the division: US14907418
- Main IPC: C12N1/20
- IPC: C12N1/20 ; C12N5/02 ; C12N15/00 ; C07K16/28 ; G01N33/574 ; C07K16/18 ; G01N33/577 ; A61K39/00 ; G01N33/68
Abstract:
The present invention is based, in part, on the discovery of galectin 1 (Gal1) epitopes against which anti-Gal1 agents can neutralize Gal1 function, as well as anti-Gal1 agents and methods useful for neutralizing Gal1 function.
Public/Granted literature
- US20210095035A1 ANTI-GALECTIN-1 (GAL1) MONOCLONAL ANTIBODIES AND FRAGMENTS THEREOF FOR NEUTRALIZING GAL1 Public/Granted day:2021-04-01
Information query
IPC分类:
